Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prescription of Valproate and Derivatives in Women of Childbearing Age: Qualitative Study
Sponsor: University Hospital, Strasbourg, France
Summary
The prescription of valproate in women of childbearing age has decreased by 82% in France, for mood disorders. Exposure to valproate during pregnancy 60%. However, the ANSM sent an alert document in August 2022 because there are still patients on valproate. In addition, there were 32 births taking valproate to mothers with bipolar disorder in 2018. The risks of exposure during pregnancy which occur in 10% of exposure cases are: congenital malformations; neurodevelopmental disorders including autism spectrum disorders, attention deficit disorders more or less hyperactivity, language disorders, motor disorders, mental delays; reduction in social, attentional, motor and language abilities; a lower level of education.
Key Details
Gender
FEMALE
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2024-01-02
Completion Date
2026-05-02
Last Updated
2024-07-12
Healthy Volunteers
No
Conditions
Locations (1)
Service de Psychiatrie 2 - CHU de Strasbourg - France
Strasbourg, France